Reta glucagon-like peptide-1 (GLP-1) receptor agonists represent a groundbreaking strategy to diabetes management. These innovative drugs function by mimicking the natural actions of GLP-1, a hormone secreted by the gut https://bookmark-share.com/story20839350/reta-glucagon-like-peptide-1-receptor-agonists